Reaction

Histiocytosis Haematophagic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,973 reports · 120 co-occurring drugs

As of the last recalculation, Histiocytosis Haematophagic appears in 2,973 FAERS reports alongside 120 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 49.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Canakinumab	74	49.1	49.4
Anakinra	110	48.2	48.5
Anti-Thymocyte Globulin (Rabbit)	44	38.7	39.0
Fludarabine Phosphate	153	28.7	28.8
Mercaptopurine	69	28.5	28.6
Etoposide	214	21.9	21.9
Ganciclovir Sodium	31	20.7	20.8
Pegaspargase	35	20.2	20.3
Ganciclovir	28	19.3	19.4
Micafungin Sodium	23	19.1	19.2
Meropenem	84	18.8	18.9
Vancomycin Hydrochloride	147	16.4	16.4
Cytarabine	130	15.8	15.8
Amphotericin B	28	15.8	15.8
Cyclosporine	232	15.7	15.8
Bleomycin Sulfate	23	15.7	15.7
Vancomycin	120	15.1	15.1
Prednisolone	340	14.8	14.8
Prednisolone Oral	340	14.8	14.8
Prednisolone Oral Solution	340	14.8	14.8
Melphalan Hydrochloride	50	14.2	14.2
Basiliximab	22	13.2	13.2
Vincristine Sulfate	54	13.1	13.1
Azathioprine	156	13.0	13.0
Tacrolimus	266	13.0	13.0
Cyclophosphamide Injection, Solution	292	12.7	12.7
Cyclophosphamide	292	12.7	12.7
Cyclophosphamide For Injection	292	12.7	12.7
Piperacillin Sodium And Tazobactam Sodium	33	11.9	11.9
Alemtuzumab	32	11.7	11.7
Busulfan	26	11.7	11.7
Melphalan	37	11.5	11.5
Itraconazole	19	11.5	11.5
Efavirenz	18	11.4	11.4
Ceftriaxone Sodium	61	11.3	11.4
Methylprednisolone	204	11.0	11.0
Sulfamethoxazole And Trimethoprim	127	11.0	11.0
Methylprednisolone Sodium Succinate	71	10.9	11.0
Dalteparin Sodium	16	10.6	10.7
Ceftriaxone	49	10.6	10.6
Piperacillin And Tazobactam	19	10.5	10.5
Tocilizumab	160	10.3	10.3
Cefepime Hydrochloride	23	10.1	10.1
Rifampicin	14	9.7	9.7
Ifosfamide	29	9.5	9.5
Gentamicin Sulfate	21	9.4	9.4
Cefepime	19	9.3	9.3
Mycophenolate Mofetil	167	9.1	9.1
Mycophenolate Mofetil Hydrochloride	167	9.0	9.1
Hydrocortisone Sodium Succinate	12	9.0	9.0
Sirolimus	17	8.9	8.9
Bendamustine Hcl	19	8.6	8.6
Gentamicin	16	8.6	8.6
Tacrolimus Ointment 0.1%	143	8.4	8.4
Tacrolimus Extended-Release Capsules	143	8.4	8.4
Isoniazid	19	8.3	8.3
Methotrexate	423	8.0	8.0
Voriconazole	34	7.9	7.9
Phenobarbital	16	7.8	7.8
Filgrastim	40	7.5	7.5
Phenytoin	22	7.4	7.4
Doxorubicin	91	7.3	7.4
Methotrexate Sodium	438	7.2	7.2
Indomethacin	13	6.9	6.9
Granisetron Hydrochloride	10	6.7	6.7
Thiotepa	9	6.6	6.6
Levofloxacin	55	6.5	6.5
Levofloxacin In 5% Dextrose	55	6.5	6.5
Mycophenilic Acid	19	6.5	6.5
Voriconazole Injection	19	6.2	6.2
Atovaquone	7	6.1	6.1
Ampicillin	7	5.9	5.9
Ampicillin Sodium	7	5.9	5.9
Piperacillin Sodium,Tazobactam Sodium	22	5.8	5.8
Ursodiol	18	5.8	5.8
Amikacin	14	5.8	5.8
Abacavir Sulfate	8	5.8	5.8
Lamivudine	25	5.7	5.7
Lopinavir And Ritonavir	11	5.7	5.7
Axicabtagene Ciloleucel	8	5.7	5.7
Tenofovir Disoproxil Fumarate Tablets	7	5.7	5.7
Dexamethasone 1.5 Mg	221	5.6	5.6
Doxorubicin Hydrochloride	26	5.6	5.6
Lamivudine Oral	20	5.6	5.6
Dexamethasone	221	5.6	5.6
Brentuximab Vedotin	8	5.5	5.5
Fluconazole	54	5.5	5.5
Linezolid	23	5.4	5.4
Cisplatin	58	5.3	5.3
Pyrazinamide	7	5.2	5.2
Propofol	27	5.2	5.2
Adalimumab-Fkjp	34	5.2	5.2
Cladribine	7	5.1	5.1
Rituximab	148	5.1	5.1
Mesna Injection	6	5.1	5.1
Adalimumab-Aaty	34	5.1	5.1
Mycophenolic Acid	23	5.1	5.1
Mesna	6	5.0	5.0
Minocycline	8	4.8	4.8
Zidovudine	9	4.7	4.7
Acyclovir	75	4.7	4.7
Lamotirigine	47	4.7	4.7
Lamotrigine Extended-Release	47	4.7	4.7
Lamotrigine Chewable Dispersible	47	4.7	4.7
Adalimumab-Adaz	34	4.6	4.6
Oxaliplatin	45	4.3	4.3
Iohexol	5	4.2	4.2
Infliximab	122	4.0	4.0
Ipilimumab	24	3.9	3.9
Daptomycin	5	3.8	3.8
Bendamustine Hydrochloride	6	3.5	3.5
Granisetron	5	3.3	3.3
Imatinib Mesylate	12	3.0	3.0
Dabrafenib	8	2.7	2.7
Nivolumab	34	2.5	2.5
Trametinib	8	2.3	2.3
Emtricitabine And Tenofovir Disoproxil Fumarate	14	2.2	2.2
Tenofovir Disoproxil Fumarate	10	2.1	2.1
Pazopanib Hydrochloride	8	2.1	2.1
Olaparib	5	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.